News | ASTRO | December 06, 2019

Hahn has served on the ASTRO Board of Directors and has broad knowledge as a clinician, researcher, educator and administrative leader

Stephen Hahn, M.D., FASTRO

Stephen Hahn, M.D., FASTRO


December 6, 2019 — The American Society for Radiation Oncology (ASTRO) expressed its support after the U.S. Senate Committee on Health, Education, Labor and Pensions voted today to approve the nomination of radiation oncologist Stephen Hahn, M,D,, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA). Next, Senate Majority Leader Mitch McConnell (R-Ky.) will need to schedule a full Senate vote to confirm Hahn.

"On behalf of our more than 10,000 members, ASTRO commends Dr. Hahn for his thoughtful answers outlining his commitment to consumer safety during the committee hearing. We are pleased that Dr. Hahn received the votes needed to secure committee approval and will move on to a final confirmation vote. We join the growing number of research, provider and patient groups who also support Dr. Hahn, and we urge the Senate to swiftly confirm his nomination as head of the FDA," said Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors.

Hahn, the chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, was nominated Nov. 1 by President Trump to be the nation’s 24th FDA Commissioner. On behalf of ASTRO, DeWeese and other radiation oncology leaders expressed their support of Dr. Hahn's nomination when it was announced by the White House. The Cancer Leadership Council, a coalition of approximately 30 professional societies, cancer patient organizations and research organizations including ASTRO, also voiced its support of Hahn earlier this week.

Related content:

ASTRO supports nomination of Stephen Hahn, M.D., FASTRO, to lead U.S. FDA


Related Content

News | Radiology Imaging

July 15, 2025 — Radiology Partners (RP), a provider of technology-enabled radiology services, has announced the launch ...

Time July 15, 2025
arrow
News | Ultrasound Imaging

July 14, 2025 — Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant ...

Time July 14, 2025
arrow
News | Lung Imaging

June 9, 2025 — bioAffinity Technologies, Inc., a biotechnology company addressing the need for noninvasive, accurate ...

Time July 10, 2025
arrow
News | ASTRO

July 9, 2025 — The American Society for Radiation Oncology (ASTRO) selected 43 members to receive the ASTRO Fellow ...

Time July 09, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | Radiation Therapy

June 12, 2025 — According to a new report published in the American Society of Radiation Oncology journal, Practical ...

Time June 12, 2025
arrow
News | Radiation Therapy

May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and ...

Time May 15, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Subscribe Now